Stock NTRR NEUTRA CORP.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Neutra Corp.

Equities

NTRR

US64129C3034

Pharmaceuticals

Market Closed - OTC Markets
Other stock markets
 15:14:35 2024-05-16 EDT 		5-day change 1st Jan Change
0.0004 USD +33.33% Intraday chart for Neutra Corp. 0.00% +33.33%
2023 Neutra Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended October 31, 2023 CI
2023 Neutra Corp. Reports Earnings Results for the Second Quarter and Six Months Ended July 31, 2023 CI

Valuation

Fiscal Period: January 2018 2019 2020 2021 2022 2023
Capitalization 1 1.573 1.043 0.493 4.777 2.156 1.197
Enterprise Value (EV) 1 1.737 1.632 0.6282 4.993 2.397 1.251
P/E ratio -2.33 x -0.2 x -0.28 x -6.58 x -2.61 x -1.94 x
Yield - - - - - -
Capitalization / Revenue - - 77,084,910 x 493,119,542 x 23,434,575 x 17,600,844 x
EV / Revenue - - 98,226,427 x 515,459,069 x 26,053,405 x 18,402,377 x
EV / EBITDA - - - -11,145,677 x -4,739,605 x -5,719,677 x
EV / FCF - 3,281,802 x 10,092,189 x -11,829,772 x -12,041,056 x -3,876,597 x
FCF Yield - 0% 0% -0% -0% -0%
Price to Book -2.06 x -1 x -0.58 x -3.92 x -1.69 x -1.66 x
Nbr of stocks (in thousands) 6,839 32,182 616,198 1,492,765 1,782,074 2,393,575
Reference price 2 0.2300 0.0324 0.000800 0.003200 0.001210 0.000500
Announcement Date 18-05-01 19-05-01 20-06-24 21-05-17 22-05-10 23-06-09
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: January 2018 2019 2020 2021 2022 2023
Net sales - - 0.006395 0.009687 0.092 0.068
EBITDA - - - -0.448 -0.5058 -0.2188
EBIT 1 -0.1637 -1.709 -0.3942 -0.4787 -0.5836 -0.2977
Operating Margin - - -6,164.89% -4,941.31% -634.23% -437.78%
Earnings before Tax (EBT) 1 -0.519 -2.429 -0.6956 -0.5389 -0.6329 -0.5579
Net income 1 -0.519 -2.429 -0.6956 -0.5389 -0.6329 -0.5614
Net margin - - -10,877.58% -5,563.04% -687.86% -825.66%
EPS 2 -0.0986 -0.1630 -0.002879 -0.000486 -0.000463 -0.000258
Free Cash Flow - 0.4973 0.0622 -0.4221 -0.1991 -0.3228
FCF margin - - 973.29% -4,357.3% -216.37% -474.7%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 18-05-01 19-05-01 20-06-24 21-05-17 22-05-10 23-06-09
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: January 2018 2019 2020 2021 2022 2023
Net Debt 1 0.16 0.59 0.14 0.22 0.24 0.05
Net Cash position 1 - - - - - -
Leverage (Debt/EBITDA) - - - -0.483 x -0.4764 x -0.2491 x
Free Cash Flow - 0.5 0.06 -0.42 -0.2 -0.32
ROE (net income / shareholders' equity) 72.1% 260% 71.2% 64.9% 69% 63.7%
ROA (Net income/ Total Assets) - -1,215% -142% -160% -227% -181%
Assets 1 - 0.2 0.4883 0.336 0.2791 0.311
Book Value Per Share 2 -0.1100 -0.0300 -0 -0 -0 -0
Cash Flow per Share - - 0 0 - -
Capex - - - 0.2 0.04 -
Capex / Sales - - - 2,028.39% 43.72% -
Announcement Date 18-05-01 19-05-01 20-06-24 21-05-17 22-05-10 23-06-09
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Pharmaceuticals

1st Jan change Capi.
NEUTRA CORP. Stock Neutra Corp.
+33.33% 875K
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+32.36% 709B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+30.77% 595B
JOHNSON & JOHNSON Stock Johnson & Johnson
-1.60% 367B
MERCK & CO., INC. Stock Merck & Co., Inc.
+20.07% 334B
ABBVIE INC. Stock AbbVie Inc.
+6.04% 289B
ASTRAZENECA PLC Stock AstraZeneca PLC
+14.77% 239B
NOVARTIS AG Stock Novartis AG
+9.13% 211B
ROCHE HOLDING AG Stock Roche Holding AG
-3.97% 203B
AMGEN INC. Stock Amgen Inc.
+9.27% 171B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. NTRR Stock
  4. Financials Neutra Corp.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW